Tarek Hamouda

2.1k total citations
22 papers, 1.6k citations indexed

About

Tarek Hamouda is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Tarek Hamouda has authored 22 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 6 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Tarek Hamouda's work include Influenza Virus Research Studies (6 papers), Respiratory viral infections research (5 papers) and Immune Response and Inflammation (5 papers). Tarek Hamouda is often cited by papers focused on Influenza Virus Research Studies (6 papers), Respiratory viral infections research (5 papers) and Immune Response and Inflammation (5 papers). Tarek Hamouda collaborates with scholars based in United States, Poland and Canada. Tarek Hamouda's co-authors include James R. Baker, Andrzej Myc, Jon D. Reuter, Chung–Horng Lung, Moataz Soliman, Jiehan Zhou, Zhengyi Cao, Jeffrey J. Landers, Joyce A. Sutcliffe and Susan Ciotti and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tarek Hamouda

22 papers receiving 1.5k citations

Peers

Tarek Hamouda

EPIDE

IMMUN

Archana Gupta India

Hongwei Cao China

Anastasios Ioannidis Greece

Lijun Wang China

Sharon Shui Yee Leung Hong Kong

Xiaofeng Li China

Kwang Hee Lee South Korea

Mohsen Tafaghodi Iran

Yanlong Yin China

Siyu Huang China

Archana Gupta India

Tarek Hamouda

889 ×2.7

195 ×0.6

EPIDE

176 ×0.6

175 ×0.8

IMMUN

218 ×1.1

Citations per year, relative to Tarek Hamouda Tarek Hamouda (= 1×) peers Archana Gupta

Countries citing papers authored by Tarek Hamouda

Since Specialization

Citations

This map shows the geographic impact of Tarek Hamouda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarek Hamouda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarek Hamouda more than expected).

Fields of papers citing papers by Tarek Hamouda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarek Hamouda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarek Hamouda. The network helps show where Tarek Hamouda may publish in the future.

Co-authorship network of co-authors of Tarek Hamouda

This figure shows the co-authorship network connecting the top 25 collaborators of Tarek Hamouda. A scholar is included among the top collaborators of Tarek Hamouda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarek Hamouda. Tarek Hamouda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bernstein, David I., Rhonda D. Cardin, Fernando Bravo, et al.. (2019). Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes. Vaccine. 37(43). 6470–6477. 27 indexed citations

Ahmed, Mushtaq, Douglas M. Smith, Tarek Hamouda, et al.. (2017). A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice. Vaccine. 35(37). 4983–4989. 39 indexed citations

O’Konek, Jessica J., Paul E. Makidon, Jeffrey J. Landers, et al.. (2015). Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats. Human Vaccines & Immunotherapeutics. 11(12). 2904–2912. 21 indexed citations

Wong, Pamela T., Pascale R. Leroueil, Douglas M. Smith, et al.. (2015). Formulation, High Throughput In Vitro Screening and In Vivo Functional Characterization of Nanoemulsion-Based Intranasal Vaccine Adjuvants. PLoS ONE. 10(5). e0126120–e0126120. 33 indexed citations

Soliman, Moataz, et al.. (2013). Smart Home: Integrating Internet of Things with Web Services and Cloud Computing. 317–320. 164 indexed citations

Makidon, Paul E., Jessica J. O’Konek, Tarek Hamouda, et al.. (2013). Intranasal immunization with W₈₀5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model. Human Vaccines & Immunotherapeutics. 10(3). 615–622. 11 indexed citations

Das, Subash C., Masato Hatta, Peter R. Wilker, et al.. (2012). Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. Vaccine. 30(48). 6871–6877. 31 indexed citations

Stanberry, Lawrence R., Jakub K. Simon, Casey Johnson, et al.. (2011). Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens. Vaccine. 30(2). 307–316. 53 indexed citations

Hamouda, Tarek, Joyce A. Sutcliffe, Susan Ciotti, & James R. Baker. (2011). Intranasal Immunization of Ferrets with Commercial Trivalent Influenza Vaccines Formulated in a Nanoemulsion-Based Adjuvant. Clinical and Vaccine Immunology. 18(7). 1167–1175. 37 indexed citations

10.

Lindell, Dennis M., Susan B. Morris, Maria P. White, et al.. (2011). A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease. PLoS ONE. 6(7). e21823–e21823. 62 indexed citations

11.

Hamouda, Tarek, А. А. Чепурнов, Nicholas Mank, et al.. (2010). Efficacy, immunogenicity and stability of a novel intranasal Nanoemulsion-adjuvanted influenza vaccine in a murine model. Human Vaccines. 6(7). 585–594. 32 indexed citations

12.

Hemmila, Mark R., Aladdein Mattar, Saman Arbabi, et al.. (2010). Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Surgery. 148(3). 499–509. 70 indexed citations

13.

Hamouda, Tarek. (2008). NB-002, a Novel Nanoemulsion with Anti-Dermatophyte Activity. 46th Annual Meeting. 2 indexed citations

14.

Myc, Andrzej, Thomas E. Vanhecke, Jeffrey J. Landers, Tarek Hamouda, & James R. Baker. (2003). The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi. Mycopathologia. 155(4). 195–201. 52 indexed citations

15.

Myc, Andrzej, Jolanta F. Kukowska‐Latallo, Anna U. Bielinska, et al.. (2003). Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion. Vaccine. 21(25-26). 3801–3814. 74 indexed citations

16.

Landers, Jeffrey J., Zhengyi Cao, Inhan Lee, et al.. (2002). Prevention of Influenza Pneumonitis by Sialic Acid–Conjugated Dendritic Polymers. The Journal of Infectious Diseases. 186(9). 1222–1230. 107 indexed citations

17.

Hamouda, Tarek, et al.. (2002). A rapid staining technique for the detection of the initiation of germination of bacterial spores. Letters in Applied Microbiology. 34(2). 86–90. 74 indexed citations

18.

Hamouda, Tarek, et al.. (2001). A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiological Research. 156(1). 1–7. 259 indexed citations

19.

Hamouda, Tarek & James R. Baker. (2000). Antimicrobial mechanism of action of surfactant lipid preparations in enteric Gram-negative bacilli. Journal of Applied Microbiology. 89(3). 397–403. 226 indexed citations

20.

Hamouda, Tarek, et al.. (1999). A Novel Surfactant Nanoemulsion with Broad‐Spectrum Sporicidal Activity againstBacillusSpecies. The Journal of Infectious Diseases. 180(6). 1939–1949. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact